ArticleEuropean urology2019

Tumour Heterogeneity and Resistance to Therapy in Prostate Cancer: A Fundamental Limitation of Prostate-specific Membrane Antigen Theranostics or a Key Strength?

Michael S Hofman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.